1. In Vivo
Pharmacodynamics of New Lipopeptide MX-2401
2. Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: The synthesis and evaluation of daptomycin (LY146032).
3. In Vitro Activity of Daptomycin against Methicillin-Resistant
Staphylococcus aureus
, Including Heterogeneously Glycopeptide-Resistant Strains
4. DugourdD, SiuR, FennJ, CameronDR, BoydVA, BordersDB, et al. 2005. Novel lipopeptide amphomycin derivatives have activity against resistant and sensitive Gram-positive bacteria. In: Abstracts of the 105th General Meeting of the American Society for Microbiology; 2005 Jun 5–9; Atlanta, GA. Washington, DC: ASM Press [AbstractA-086].
5. DugourdD, SiuR, FennJ, CameronDR, BoydVA, Wacowich-SgarbiS, SgarbiPWM, JiaQ, ClementJJ. 2006.In vitrocharacterization of MX-2401 – a novel amphomycin derivative active against Gram positive bacteria. In: Abstracts of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2006 Sep 27–30; SanFrancisco, CA. Washington, DC: ASM Press [Abstract F1-1879].